Aspirin and clopidogarel resistance

被引:1
作者
Fosburgh, Daniel [1 ]
机构
[1] Colorado Permanente Med Grp, Denver, CO USA
关键词
D O I
10.4065/81.7.989
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:989 / 989
页数:1
相关论文
共 12 条
[1]  
[Anonymous], 2002, **DROPPED REF**
[2]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[3]   Clopidogrel and aspirin versus aspirin alone for the prevention of atherothrombotic events [J].
Bhatt, DL ;
Fox, KAA ;
Hacke, W ;
Berger, PB ;
Black, HR ;
Boden, WE ;
Cacoub, P ;
Cohen, EA ;
Creager, MA ;
Easton, JD ;
Flather, MD ;
Haffner, SM ;
Hamm, CW ;
Hankey, GJ ;
Johnston, SC ;
Mak, KH ;
Mas, JL ;
Montalescot, G ;
Pearson, TA ;
Steg, PG ;
Steinhubl, SR ;
Weber, MA ;
Brennan, DM ;
Fabry-Ribaudo, L ;
Booth, J ;
Topol, EJ ;
Frye, RL ;
Amarenco, P ;
Brass, LM ;
Buyse, M ;
Cohen, LS ;
DeMets, DL ;
Fuster, V ;
Hart, RG ;
Marler, JR ;
McCarthy, C ;
Schoemig, A ;
Lincoff, AM ;
Brener, SJ ;
Sila, CA ;
Albuquerque, A ;
Aroutiounov, G ;
Artemiev, D ;
Atkeson, BG ;
Bartel, T ;
Basart, DCG ;
Lima, AB ;
Belli, G ;
Bordalo e Sa, AL ;
Bosch, X .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (16) :1706-1717
[4]   Pharmacokinetic and pharmacodynamic differences between two low dosages of aspirin may affect therapeutic outcomes [J].
Cerletti, C ;
Dell'Elba, G ;
Manarini, S ;
Pecce, R ;
Di Castelnuovo, A ;
Scorpiglione, N ;
Feliziani, V ;
de Gaetano, G .
CLINICAL PHARMACOKINETICS, 2003, 42 (12) :1059-1070
[5]   Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events [J].
Eikelboom, JW ;
Hirsh, J ;
Weitz, JI ;
Johnston, M ;
Yi, Q ;
Yusuf, S .
CIRCULATION, 2002, 105 (14) :1650-1655
[6]   ENDOGENOUS BIOSYNTHESIS OF PROSTACYCLIN AND THROMBOXANE AND PLATELET-FUNCTION DURING CHRONIC ADMINISTRATION OF ASPIRIN IN MAN [J].
FITZGERALD, GA ;
OATES, JA ;
HAWIGER, J ;
MAAS, RL ;
ROBERTS, LJ ;
LAWSON, JA ;
BRASH, AR .
JOURNAL OF CLINICAL INVESTIGATION, 1983, 71 (03) :676-688
[7]   Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities [J].
Grosser, T ;
Fries, S ;
FitzGerald, GA .
JOURNAL OF CLINICAL INVESTIGATION, 2006, 116 (01) :4-15
[8]   Low-dose aspirin increases aspirin resistance in patients with coronary artery disease [J].
Lee, PY ;
Chen, WH ;
Ng, W ;
Cheng, X ;
Kwok, JYY ;
Tse, HF ;
Lau, CP .
AMERICAN JOURNAL OF MEDICINE, 2005, 118 (07) :723-727
[9]   Aspirin and clopidogrel resistance [J].
Michos, ED ;
Ardehali, R ;
Blumenthal, RS ;
Lange, RA ;
Ardehali, H .
MAYO CLINIC PROCEEDINGS, 2006, 81 (04) :518-526
[10]   Effects of aspirin dose when used alone or in combination with clopidogrel in patients with acute coronary syndromes - Observations from the Clopidogrel in Unstable angina to prevent Recurrent Events (CURE) study [J].
Peters, RJG ;
Mehta, SR ;
Fox, KAA ;
Zhao, F ;
Lewis, BS ;
Kopecky, SL ;
Diaz, R ;
Commerford, PJ ;
Valentin, V ;
Yusuf, S .
CIRCULATION, 2003, 108 (14) :1682-1687